Disufenton Free Base | CAS# 168021-77-0 (free base) | stroke

MedKoo Cat#: 413839 | Name: Disufenton Free Base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Disufenton Free Base is a nitrone benzene bissulfonate in development for stroke.

Chemical Structure

Disufenton Free Base

CAS#168021-77-0 (free base)

Theoretical Analysis

MedKoo Cat#: 413839

Name: Disufenton Free Base

CAS#: 168021-77-0 (free base)

Chemical Formula: C11H15NO7S2

Exact Mass: 337.0290

Molecular Weight: 337.36

Elemental Analysis: C, 39.16; H, 4.48; N, 4.15; O, 33.20; S, 19.01

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

168021-77-0 (free base) 168021-79-2 (sodium)

Synonym

Disufenton Free Base; UNII-797K01YF1M

IUPAC/Chemical Name

(Z)-N-tert-butyl-1-(2,4-disulfophenyl)methanimine oxide

InChi Key

OVTCHWSLKGENKP-GHXNOFRVSA-N

InChi Code

InChI=1S/C11H15NO7S2/c1-11(2,3)12(13)7-8-4-5-9(20(14,15)16)6-10(8)21(17,18)19/h4-7H,1-3H3,(H,14,15,16)(H,17,18,19)/b12-7-

SMILES Code

CC(C)(/[N+]([O-])=C/c1c(S(=O)(O)=O)cc(S(=O)(O)=O)cc1)C

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 337.36 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Choi SH, Choi CH. Noise-Induced Neural Degeneration and Therapeutic Effect of Antioxidant Drugs. J Audiol Otol. 2015 Dec;19(3):111-9. doi: 10.7874/jao.2015.19.3.111. Epub 2015 Dec 18. PMID: 26771008; PMCID: PMC4704551. 2: Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007 Jul-Aug;29(6):427-37. PMID: 17922073. 3: Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2006 May;28(4):233-77. PMID: 16801985. 4: Wang CX, Shuaib A. Neuroprotective effects of free radical scavengers in stroke. Drugs Aging. 2007;24(7):537-46. doi: 10.2165/00002512-200724070-00002. PMID: 17658905. 5: Bayés M, Rabasseda X. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2008 Jan-Feb;30(1):67-99. PMID: 18389098. 6: Dolgin E. To serve and neuroprotect. Nat Med. 2012 Jul 6;18(7):1003-6. doi: 10.1038/nm0712-1003. PMID: 22772545. 7: Lapchak PA. NXY-059. Centaur. Curr Opin Investig Drugs. 2002 Dec;3(12):1758-62. PMID: 12528313. 8: Jönsson S, Cheng YF, Edenius C, Lees KR, Odergren T, Karlsson MO. Population pharmacokinetic modelling and estimation of dosing strategy for NXY-059, a nitrone being developed for stroke. Clin Pharmacokinet. 2005;44(8):863-78. doi: 10.2165/00003088-200544080-00007. PMID: 16029070. 9: Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Neuroprotection for stroke: current status and future perspectives. Int J Mol Sci. 2012;13(9):11753-72. doi: 10.3390/ijms130911753. Epub 2012 Sep 18. PMID: 23109881; PMCID: PMC3472773. 10: Leker RR, Eichel R, Rafaeli G, Ben-Hur T. Novel therapies for acute ischemic stroke. Isr Med Assoc J. 2006 Nov;8(11):788-92. PMID: 17180832.